These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9876532)

  • 1. In vivo characteristics of injectable poly(DL-lactic acid) microspheres for long-acting drug delivery.
    Kobayashi D; Tsubuku S; Yamanaka H; Asano M; Miyajima M; Yoshida M
    Drug Dev Ind Pharm; 1998 Sep; 24(9):819-25. PubMed ID: 9876532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
    Yamakawa I; Tsushima Y; Machida R; Watanabe S
    J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
    Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
    Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of high-content aripiprazole-loaded core-shell structure microsphere for long-release injectable formulation.
    Hiraoka S; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2014; 62(7):654-60. PubMed ID: 24990503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
    Hyon SH
    Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A basic study on usefulness of bleomycin incorporated in poly DL-lactic acid].
    Kumanohoso T; Natsugoe S; Shimada M; Sagara M; Aikou T; Shimazu H; Shinkawa T; Nakamura K; Fukuzaki H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1572-4. PubMed ID: 7690536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres.
    Urata T; Arimori K; Nakano H
    J Control Release; 1999 Mar; 58(2):133-41. PubMed ID: 10053186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of oil-in-water type poly (D,L-lactic acid) microspheres containing testosterone enanthate.
    Tsubuku S; Sugawara S; Miyajima M; Yoshida M; Asano M; Okabe K; Kobayashi D; Yamanaka H
    Drug Dev Ind Pharm; 1998 Oct; 24(10):927-34. PubMed ID: 9876547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of implant tablet for a week-long sustained release.
    Takahashi M; Onishi H; Machida Y
    J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of injectable Mitoxantrone poly (lactic acid)/fullerene implants for in vivo chemo-photodynamic therapy.
    Li Z; Zhang FL; Pan LL; Zhu XL; Zhang ZZ
    J Photochem Photobiol B; 2015 Aug; 149():51-7. PubMed ID: 26046749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite microparticles with in vivo reduction of the burst release effect.
    Sheikh Hassan A; Sapin A; Lamprecht A; Emond E; El Ghazouani F; Maincent P
    Eur J Pharm Biopharm; 2009 Nov; 73(3):337-44. PubMed ID: 19651210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
    Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
    Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.